Category survey

Brain image processing with Alpha-Stable distributions. Applications to intensity normalization, segmentation and diagnosis of Parkinsonian syndrome and Alzheimer’s disease. Fellowships Alzheimer’s disease & other dementias 2016    

Structural and biochemical basis of protein amyloid evolution Fellowships Alzheimer’s disease & other dementias 2016    

Vascular and Aymloid Predictors of Neurodegeneration and Cognitive Decline in Nondemented Subjects. Fellowships Alzheimer’s disease & other dementias 2016    

TOPIC: Targeting Cytotoxic Protein Oligomers Fellowships Huntington’s disease 2016    

Vascular Dementia: revealing the detrimental synergy between hypertension, micro-strokes and Neuro-Vascular Decoupling Fellowships European Commission Alzheimer’s disease & other dementias 2016    

Cortico-Spinal Motor Neurons in Amyotrophic Lateral Sclerosis : Contribution, Mechanisms and Therapy Fellowships European Commission Motor neurone diseases 2016    

Misfolded SOD1 Toxicity in Amyotrophic Lateral Sclerosis Fellowships Motor neurone diseases 2016    

Training in neurodegeneration, therapeutics intervention and neurorepair Fellowships Neurodegenerative disease in general 2016    

Small molecules activating RET for the treatment of Parkinson’s disease Fellowships Parkinson’s disease & PD-related disorders 2016    

Patient-specific stem cell-derived models for Alzheimer’s disease and related neurodegenerative disorders Fellowships Alzheimer’s disease & other dementias 2016    

Transferring NOn autonomous cell degeneration models between EU and USA for development of effective therapies for Motor Neuron Diseases (MND). Fellowships Motor neurone diseases 2016    

Development of a multiplex nanofluidic assay for selective detection and monitoring of Alzheimer’s disease biomarkers Fellowships Alzheimer’s disease & other dementias 2016    

Elucidating pathways from hereditary Alzheimer mutations to pathological tau phenotypes Fellowships Alzheimer’s disease & other dementias 2016    

Plasticity of the Burst-Pause Response in the Tonically Active Cholinergic Interneurons of the Striatum in Normal and Parkinsonian Mice Fellowships Parkinson’s disease & PD-related disorders 2016    

Happy or Sad? The Influence of Emotional Body Cues on Facial Expression Perception in Huntington’s Disease Fellowships Huntington’s disease 2016    

Prion Detection Through Organized Arrays of Gold Nanorods as SERS Substrates Fellowships Prion disease 2016    

Nanomaterials for treatment of neurodegenerative disorders Fellowships Neurodegenerative disease in general 2016    

Structural analysis of the conformational transitions of the K18 fragment of human tau driven by Hsp70 action Fellowships Neurodegenerative disease in general 2016    

Targeted Brain Delivery of Nrf-2 Gene and α-Synuclein Binding Peptide using Functionalised Gold Nanoparticles for Disease-modifying Therapy of Parkinson’s Disease Fellowships Parkinson’s disease & PD-related disorders 2016    

Nanocatalytic drugs towards Alzheimer’s disease Fellowships Alzheimer’s disease & other dementias 2016    

Gene-Environment Interactions in the Etiopathogenesis of Parkinson’s Disease: Role of Inflammation Fellowships Parkinson’s disease & PD-related disorders 2016    

Regulation of cryptic splice sites in neuronal differentiation and disease Fellowships Motor neurone diseases 2016    

Discovery of drugs for the treatment and prevention of Alzheimer’s disease Fellowships Alzheimer’s disease & other dementias 2016    

Immune responses in neurodegenerative diseases: Protection or progression? Fellowships Alzheimer’s disease & other dementias 2016    

Development of a late-onset-Alzheimer’s disease (LOAD) profile for accurate diagnosis and identification of potential therapeutic approaches Fellowships Alzheimer’s disease & other dementias 2016    

Identification and validation of cerebral KCa3.1 potassium channels a drug tragets for the prevention and treatment of cerebral ischemia associated with diabetes and Alzheimers disease Fellowships Alzheimer’s disease & other dementias 2016    

Presenilin 2 – a protector against Alzheimer’s disease Fellowships Alzheimer’s disease & other dementias 2016    

DElineation of Striato-CoRtical contrIbutions to BEhavioral symptoms in FrontoTemporal Dementia Fellowships Alzheimer’s disease & other dementias 2016    

From Brain Gene Transfer Towards Gene Therapy: Pharmacological Assessment of AAV, CAV and LVV Fellowships Parkinson’s disease & PD-related disorders 2016    

EID on the advanced science and technology of rat models for neurodegenerative diseases Fellowships Neurodegenerative disease in general 2016    

Mechanisms of cell dysfunction by aggregation dynamics of polyQ-containing proteins Fellowships Neurodegenerative disease in general 2016    

Non-conventional target approach for drug discovery against neurodegenerative diseases: Nrf2 upregulation Fellowships Neurodegenerative disease in general 2016    

Clot formation as a potential diagnostic tool and therapeutic target for Alzheimer’s disease Fellowships Alzheimer’s disease & other dementias 2016    

Industrial Academic Initial Training Network towards focused treatment of age-related motor symptoms. Fellowships Parkinson’s disease & PD-related disorders 2016    

Switching the disease off: Effects of spatial and temporal inactivation of mutant huntingtin in Huntington disease Fellowships Huntington’s disease 2016    

Variabilité cérébrale comme marqueur de conversion vers une maladie neurodégénérative dans le trouble comportemental en sommeil paradoxale idiopathique. Cerebral variability as a marker of conversion to a neurodegenerative disease in idiopathic paradoxical sleep disorder Fellowships Canada Parkinson’s disease & PD-related…

Developing an intervention to enhance social connectedness and improve quality of life for people with dementia in long-term care Fellowships Canada Alzheimer’s disease & other dementias 2016    

Investigating fornix integrity as a sensitive biomarker in individuals who show the earliest signs of Alzheimer’s disease Fellowships Canada Alzheimer’s disease & other dementias 2016    

Cellular and Genetic Mechanisms of Dopamine Transporter-associated Parkinsonism Fellowships Denmark Parkinson’s disease & PD-related disorders 2016    

WNT SIGNALING IN DOPAMINE DIFFERENCIATION OF STEM CELLS AND CELL REPLACEMENT THERAPY FOR PARKINSON’S DISEASE. Fellowships Denmark Parkinson’s disease & PD-related disorders 2016    

Defining the genetic etiology of Alzheimer’s disease in the Faroe Islands Fellowships Denmark Alzheimer’s disease & other dementias 2016    

Activated microglia regulate neuronal secretion of α-synuclein by exophagy through activation of neuronal JNK stress kinase Fellowships Denmark Alzheimer’s disease & other dementias 2016    

NOVEL PET IMAGING MARKERS FOR THE EARLY AND PRO-DROMAL PHASE OF PARKINSON’S DISEASE. Fellowships Denmark Parkinson’s disease & PD-related disorders 2016    

Rehabilitation and dementia – based on user perspective Fellowships Denmark Alzheimer’s disease & other dementias 2016    

Bridging the world of fungi and dementia Fellowships Alzheimer’s disease & other dementias 2016    

Presynaptic and astrocytic role of Amyloid precursor protein signaling in the hippocampus Fellowships Alzheimer’s disease & other dementias 2016    

Non-amyloid-related hippocampal network dysfunction as an early biomarker of Alzheimer’s disease Fellowships Alzheimer’s disease & other dementias 2016    

Insight into the synergistic interactions between Aβ amyloid, α-synuclein and Tau Fellowships Neurodegenerative disease in general 2016    

Investigation of the relationship between the material properties of insoluble, protein aggregates known as amyloids and common forms of age-related dementia such as Alzheimer’s and Parkinson’s. Fellowships Alzheimer’s disease & other dementias 2016    

BILIVERDIN REDUCTASE-A IN BRAIN INSULIN SIGNALING AND OXIDATIVE STRESS- MEDIATED NEURODEGENERATION Fellowships Alzheimer’s disease & other dementias 2016